Literature DB >> 29953794

Suppressing stathmin-l can inhibit chkl protein expression and reduce the invasion and tumorigenicity of cervical cancer cells.

Sh F Kong, T Lv, X Sun, H Yuan, J Y Zhong, X R Li, S Zh Dai.   

Abstract

The purpose of this study was to evaluate the effects of stathmin-l on chkl protein expression in cervical cancer cells and the influ- ences on the cells' invasion and tumorigenicity. Suppressed stathmin-l expression in Hela cells and C33A cells by lentiviral vector were utilized. Real time PCR and Western blot were used to examine the expression of chkl. Cell proliferation and invasion were stud- ied using MTT assays and transwell migration assays.The differences of tumorigenicity in vivo were explored using xenograft experi- ments. In addition, stathmin-l expressions in 24 cervical cancer patients were studied without regional lymph nodes metastasis and 16 metastatic patients by immunohistochemistry assays and real time PCR. This study found downregulating stathmin-l reduced chkl ex- pressions and the proliferation and invasion in cervical cancer cells and reduced the tumorigenicity of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29953794

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  1 in total

1.  STMN1 and MKI67 Are Upregulated in Uterine Leiomyosarcoma and Are Potential Biomarkers for its Diagnosis.

Authors:  Xianqing Hu; Hongping Zhang; Xiaodong Zheng; Zhongmin Lin; Guofei Feng; Yanmei Chen; Qionghui Pan; Feifei Ni
Journal:  Med Sci Monit       Date:  2020-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.